Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 7.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 001A61 | D. S. Courvoisier [Suisse] ; D. Alpizar-Rodriguez [Suisse] ; J. E. Gottenberg [France] ; M. V. Hernandez [Espagne] ; F. Iannone [Italie] ; E. Lie [Norvège] ; M. J. Santos [Portugal] ; K. Pavelka [République tchèque] ; C. Turesson [Suède] ; X. Mariette [France] ; D. Choquette [Canada] ; M. L. Hetland [Danemark] ; A. Finckh [Suisse] | Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study |
| 002355 | P. Emery [Royaume-Uni] ; J E Gottenberg [France] ; A. Rubbert-Roth [Allemagne] ; P. Sarzi-Puttini [Italie] ; D. Choquette [Canada] ; V M Martínez Taboada [Espagne] ; L. Barile-Fabris [Mexique] ; R J Moots [Royaume-Uni] ; A. Ostor [Royaume-Uni] ; A. Andrianakos [Grèce] ; E. Gemmen [États-Unis] ; C. Mpofu [Suisse] ; C. Chung [États-Unis] ; L Hinsch Gylvin [Suisse] ; A. Finckh [Suisse] | Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study |
| 002632 | Alex Diamantopoulos [Royaume-Uni] ; A. Finckh [Suisse] ; T. Huizinga [Pays-Bas] ; D. K. Sungher [Royaume-Uni] ; L. Sawyer [Royaume-Uni] ; D. Neto [Suisse] ; F. Dejonckheere [Suisse] | Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK |
| 002A20 | C. Gabay ; M. Riek [Suisse] ; A. Scherer [Suisse] ; A. Finckh | THU0135 Shorter Drug Retention in Rheumatoid Arthritis Patients Treated with Biological Dmards in Monotherapy – an Observational Cohort Analysis |
| 002A24 | B. Möller [Suisse] ; A. Scherer [Suisse] ; P. M. Villiger [Suisse] ; A. Finckh [Suisse] | THU0129 Anemia Adds Information to Predict Radiographic Progression of Erosions on All Levels Levels of Clinically Assessed Disease Activity |
| 002B76 | S. Martin-Du-Pan ; D. Neto ; P. Zufferey [Suisse] ; A. Ciurea ; H. Ziswiler [Suisse] ; C. Gabay ; A. Finckh | SAT0104 Comparison of Drug Discontinuation to Inefficacy and Adverse Events Between Anti-Tnf Agents and ‘Non-Anti-Tnf Biologic Agents’ in Anti-Tnf Inadequate Responder Rheumatoid Arthritis Patients |
| 003C79 | A. Finckh [Suisse] ; A. Ciurea [Suisse] ; L. Brulhart [Suisse] ; B. Möller [Suisse] ; U A Walker [Suisse] ; D. Courvoisier [Suisse] ; D. Kyburz [Suisse] ; J. Dudler [Suisse] ; C. Gabay [Suisse] | Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? |
| This area was generated with Dilib version V0.6.34. |  |